Cargando…
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up
We report the case of a 38-year-old patient who was diagnosed with a cerebellar well-differentiated neuroendocrine tumor (WDNET) in 2009. At first glance, we believed that it was a metastasis from an unrecognized WDNET arising outside the cerebellum. However, despite a prolonged follow-up of 6 years...
Autores principales: | Vernieri, Claudio, Femia, Daniela, Pusceddu, Sara, Capella, Carlo, Rosai, Juan, Calareso, Giuseppina, Concas, Laura, Prinzi, Natalie, Russo, Giuseppe Lo, de Braud, Filippo, Buzzoni, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043191/ https://www.ncbi.nlm.nih.gov/pubmed/27721764 http://dx.doi.org/10.1159/000447771 |
Ejemplares similares
-
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
por: Pusceddu, Sara, et al.
Publicado: (2016) -
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study
por: Pusceddu, Sara, et al.
Publicado: (2021) -
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
por: Vernieri, Claudio, et al.
Publicado: (2019) -
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence
por: Pusceddu, Sara, et al.
Publicado: (2020) -
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2020)